ArticleInternational ophthalmology2025
von Willebrand factor A domain containing 8 (VWA8)- associated retinitis pigmentosa: description of a novel case and expansion of the phenotype.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeRetinitis pigmentosa, the most common type of inherited retinal dystrophy, is known to have great genetic heterogeneity, as pathogenic variants in approximately 100 genes have been recognized as causative. In the last decade, wide application of next-generation DNA sequencing has allowed identification of pathogenic variants in novel retinal dystrophies genes. Recently, a pathogenic variant in von Willebrand factor A domain containing protein 8 (VWA8) gene, was demonstrated to segregate in a large Chinese family with autosomal dominant (AD) retinitis pigmentosa. The current study describes the clinical and molecular characteristics of a novel retinitis pigmentosa patient carrying a pathogenic variant in the VWA8 gene.
methodsOphthalmic examination, fundus photography, autofluorescence, spectral-domain optical coherence tomography, Goldmann perimetry, Full Field Stimulus Threshold (FST), full-field electroretinogram, and chromatic perimetry testing were carried out. Peripheral blood DNA was isolated, and whole exome sequencing was performed in the index case. Bioinformatic analysis was performed for the identification of the pathogenic causal variant. Analysis of the candidate variant in first-degree relatives by Sanger DNA sequencing was also performed.
resultsA Mexican patient suffering from retinitis pigmentosa and her first-degree relatives were included. Classical features of retinal dystrophy were identified, including nyctalopia, peripheral visual field loss, as well as vascular attenuation, and bone spicules on fundus examination. Genetic analysis identified a novel pathogenic c.3069C > G (p.Tyr1023Ter) heterozygous VWA8 variant. Additionally, optic nerve drusen were identified, a feature not described in the family previously reported in literature.
conclusionOur results confirm VWA8 as a retinitis pigmentosa-associated gene and contributes to the phenotypic expansion of the disorder.
Indexed as
Identifiers
40638000What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.